29 Aug 2017

GW Pharma plans to expand marijuana operations in UK

One of the world’s biggest marijuanas companies – GW Phamaceuticals – is poised to get even bigger. The company announced that it’s planning an expansion in the United Kingdom, including the cultivation and processing of non-psychoactive cannabis, The Telegraph of London reported. GW Pharma’s plan stems from “anticipated demand” for a CBD-based drug, Sativex, designed to help treat epilepsy, a company official told the newspaper. The Cambridge, England-based company is planning to invest 50 million British pounds ($64.6 million) on the expansion over the next three years and will hire 70 new staffers to increase its U.K. ... GW Pharma plans to expand marijuana operations in UK is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs


InvestInCannabis.com - Homepage Request Form

Request an Invitation

eCann Media is proud to showcase our portfolio of investments and subsidiaries. We have completed numerous investments across multiple verticals and sectors in the cannabis industry. Requesting an invitation will enable the eCann team to consider your eligibility for investment as well help us to identify the opportunities that best fit your needs and investment objectives.


Captcha

Please enter the characters you see in this picture:

Visual CAPTCHA

This helps prevent automated form submissions. If you are not sure what the characters are, make your best guess. You will have another try in the next screen.
Can't see the image? Click here for an audible version in English.

Need assistance with this form?